| Tag | Content |
|---|
EnhancerAtlas ID | HS020-03166 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr1:161580830-161583270 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | TFAP2A | MA0003.3 | chr1:161581075-161581086 | CGCCTCAGGCT | + | 6.14 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161581253 | 161581372 | | chr1 | 161582212 | 161582506 | | chr1 | 161581400 | 161582169 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | AGATGAACAG ACAAGTTGCA AAGATACTAC ATAAAGTTAT TACTCTATAT CCTTTCTACT 60
TCCCCTAATG TTAAAACCTT ACATAACCAT GTTATATTTA TCAAACCTAA GAAATTGGCA 120
TTGGTATAAC ATTAATGACT TTTTTTTTTT TTTTTGGACA CAGGGTCTCA CTCTGTACCC 180
CAGCCTGGAG TGCAGTGGCA CGATCTCGGC TCACTGCAAC CTCTGCCCCC TGGGCTCAAG 240
AGATTCGCCT CAGGCTCCCG GAGTAGCTGG GACTACAGGC GCGAACCCCG GGTACTTGGG 300
AGGCTGAGGC ACGAGAACCG CGTGGACCGG GAAGACGGAG GCTGCAGTGA GCCAAGATCG 360
CGCCACAGTA CTCCAGCCTG GGGTACAGAG TGAGAACCTG TCTCAAAAAA AAAAAAAAAA 420
AAGCTGGGGA GCGGGGCAAG GCGGTGGAGA ATCTGATCCT TACCAAAGTT TGACACTACT 480
GCGTTAGCGT TAAAAAAAAA ACCCAGCTAA GACTGTAGAG CAAATTAAAG GATCCTGTGT 540
TGAGGGCGTT CTCTTGTTTA GTCAAAGGAG ATGGTATCTG CCTGCCTTAG TGTGCTTGAC 600
GCACAGAAAG GGCTCAACAC ATTGTTGTTG AATAAAAGAA TGGATAAATT GACACTGGGA 660
AGTTGGAGTC CAAAGTTAAA CTTAGTCTCA ACTGCTCCCT GTTTTCATAG ACCAGACTCC 720
AGCCTACAAT ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA CAAATAATTT 780
TCGTAAATGT AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG TCTTTCTCTA 840
AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA 900
TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA 960
GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT 1020
AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT 1080
TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC 1140
TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC 1200
TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC 1260
CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC 1320
CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG 1380
AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT 1440
TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT 1500
TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG 1560
GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG 1620
AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG 1680
TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG 1740
GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG 1800
CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT 1860
CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT 1920
TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG 1980
GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT 2040
GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG 2100
AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA AGGTCCCAGG 2160
CCAACCTAAA TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC CTTCCCGTTT 2220
CCAGTCCATA AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT CGGGCCCCCT 2280
CTCTGCTGGC AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA CTGAGTTACA 2340
TGGGAGAGAA GCAGGGATTC AGTTTGGCTG GGAATCAAAC TCTTTTGATA ATTTCCTAAT 2400
AAACTGATAG TCATTAGATG ACTTGTAGTC TCGATAAGTT 2440
|
